BINEX Co., Ltd. (KOSDAQ: 053030)

Market Cap	624.21B
Revenue (ttm)	129.61B
Net Income (ttm)	-25.17B
Shares Out	31.85M
EPS (ttm)	-814.00
PE Ratio	n/a
Forward PE	44.27
Dividend	n/a
Ex-Dividend Date	n/a

Volume	823,724
Average Volume	849,679
Open	19,650
Previous Close	19,620
Day's Range	19,150 - 20,500
52-Week Range	8,250 - 27,300
Beta	0.56
RSI	54.68
Earnings Date	Feb 28, 2025

About BINEX

BINEX Co., Ltd. operates as a pharmaceutical company in South Korea. The company engages in cell line and process development, and analytical method production development. It is also involved in cell cultivation and microbial fermentation modalities process production. In addition, the company offers chemical pharmaceutical products. BINEX Co., Ltd. was founded in 1957 and is headquartered in Busan, South Korea.

• Industry: Pharmaceutical Preparations
• Founded: 1957
• Employees: 582
• Stock Exchange: KOSDAQ
• Ticker Symbol: 053030

Financial Performance

In 2023, BINEX's revenue was 154.82 billion, a decrease of -1.18% compared to the previous year's 156.68 billion. Earnings were 4.67 billion, a decrease of -62.47%.